Your shopping cart is currently empty

GS-443902 trisodium (GS-441524 triphosphate trisodium), the active triphosphate metabolite of Remdesivir (GS-5734), serves as a potent inhibitor of viral RNA-dependent RNA-polymerases (RdRp), displaying inhibitory concentrations (IC50) of 1.1 μM for RSV RdRp and 5 μM for HCV RdRp.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 5 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | GS-443902 trisodium (GS-441524 triphosphate trisodium), the active triphosphate metabolite of Remdesivir (GS-5734), serves as a potent inhibitor of viral RNA-dependent RNA-polymerases (RdRp), displaying inhibitory concentrations (IC50) of 1.1 μM for RSV RdRp and 5 μM for HCV RdRp. |
| Targets&IC50 | HCV RdRp:5 µM (IC50), RdRp (RSV):1.1 µM (IC50) |
| In vitro | During a 72-hour incubation with 1 μM Remdesivir (GS-5734), levels of its metabolite, GS-443902 trisodium (GS-441524 triphosphate trisodium; Remdesivir metabolite trisodium), were monitored at intervals of 2, 24, 48, and 72 hours, showing peak concentrations (C max) of 300, 110, and 90 pmol/million cells in macrophages, HMVEC, and HeLa cell lines, respectively[1]. GS-443902 trisodium (compound 8a), a triphosphate (TP) derivative[2], impairs RSV RdRp-catalyzed RNA synthesis through integration into the nascent viral RNA, resulting in its premature termination. It is effectively transformed within cells to GS-443902 sodium, which selectively disrupts Ebola virus (EBOV) replication by targeting and inhibiting the viral RNA-dependent RNA polymerase (RdRp), thus blocking viral RNA synthesis[3]. |
| In vivo | Remdesivir (GS-5734; 10?mg?kg; i.v.) rapidly distributes into peripheral blood mononuclear cells (PBMCs), and efficient conversion to GS-443902 trisodium (Remdesivir metabolite trisodium; NTP) is apparent within 2?h of dose administration in rhesus monkeys. In PBMCs, GS-443902 trisodium represents the predominant metabolite and is persistent with a t 1/2 of 14?h and levels required for >50% virus inhibition for 24?hours[3]. |
| Synonyms | Remdesivirmetabolitetrisodium, GS-441524triphosphatetrisodium |
| Formula | C12H16N5O13P3.xNa |
| Cas No. | 1355050-21-3 |
| Smiles | C(#N)[C@]1(O[C@H](COP(OP(OP(=O)(O)O)(=O)O)(=O)O)[C@@H](O)[C@H]1O)C=2N3C(=CC2)C(N)=NC=N3.[Na] |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.